DB
REGN icon

Danske Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Danske Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.2M Buy
107,830
+610
+0.6% +$415K 0.13% 129
2026
Q1 		$82.8M Buy
107,220
+7,918
+8% +$6.06M 0.2% 99
2025
Q4 		$76.6M Buy
99,302
+43,775
+79% +$29.7M 0.18% 104
2025
Q3 		$31.2M Buy
55,527
+4,865
+10% +$2.75M 0.08% 215
2025
Q2 		$26.6M Sell
50,662
-12,648
-20% -$7.06M 0.07% 234
2025
Q1 		$40.2M Buy
63,310
+3,216
+5% +$2.21M 0.12% 146
2024
Q4 		$42.8M Sell
60,094
-8,923
-13% -$7.49M 0.13% 138
2024
Q3 		$72.6M Buy
69,017
+1,337
+2% +$1.49M 0.24% 72
2024
Q2 		$71.1M Buy
67,680
+13,502
+25% +$13.1M 0.26% 65
2024
Q1 		$52.1M Buy
+54,178
New +$51.5M 0.16% 120

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Danske Bank's REGN Position: Q2 2026 in Review

Danske Bank increased its Regeneron Pharmaceuticals (REGN) stake by 0.57% in Q2 2026, buying an estimated $415K and bringing the position to 107,830 shares worth $67.2M. The position accounts for 0.13% of the portfolio, ranked #129.

Danske Bank first reported a position in REGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $82.8M in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Danske Bank held 107,830 shares of Regeneron Pharmaceuticals worth $67.2M as of Q2 2026.
  • Danske Bank bought 610 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $415K.
  • Regeneron Pharmaceuticals made up 0.13% of Danske Bank's portfolio in Q2 2026, its #129 holding.
  • Danske Bank first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Regeneron Pharmaceuticals position peaked at $82.8M in Q1 2026.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.